Tizanidine for Spasticity Management

Introduction to Tizanidine

Tizanidine is a centrally acting alpha-2 adrenergic receptor agonist that functions as a muscle relaxant for treating spasticity (increased muscle tone) 1
The American Heart Association recommends Tizanidine for treating spasticity resulting in pain, poor skin hygiene, or decreased function in patients with chronic stroke 2

Tizanidine has shown efficacy for acute low back pain in clinical trials, though it is not FDA-approved for this indication 3

Tizanidine can cause significant hypotension, which requires monitoring 1
Tizanidine is specifically for treating spasticity (increased muscle tone), not hypotonia (reduced muscle tone) 1
For patients who do not respond to oral medications like tizanidine, more invasive options such as botulinum toxin injections, intrathecal baclofen, or neurosurgical procedures may be considered 1
When used for non-FDA approved indications such as low back pain, treatment duration in clinical trials was typically 2 weeks or less 3
Unlike diazepam or other benzodiazepines, tizanidine is not contraindicated during stroke recovery 2

The American College of Physicians recognizes tizanidine as an option for short-term relief of acute low back pain, which may include sciatica, based on evidence from studies published in the Annals of Internal Medicine 4, 5
The American Geriatrics Society recommends a starting dose of 2 mg up to three times daily for older persons, which is applicable to patients with moderate renal impairment 6
For patients with sciatica and moderate renal impairment, a dose of 2mg twice daily is within appropriate dosing parameters, according to guidelines from the Journal of the American Geriatrics Society 6

Clinical guidelines suggest limiting treatment duration with muscle relaxants like tizanidine to short-term relief of acute low back pain, as recommended by the American College of Physicians 4, 5
Alternative treatments such as non-pharmacological approaches or other medication classes may be considered if the patient does not respond adequately or experiences adverse effects, based on recommendations from the American College of Physicians 4, 7

Tizanidine is recommended for chronic stroke patients whose spasticity causes pain, poor skin hygiene, or reduced functional ability. 8

After conservative measures such as positioning, passive stretching, and range‑of‑motion exercises have been tried, tizanidine is employed as a second‑line pharmacologic intervention for spasticity. 8

When oral agents including tizanidine fail to achieve adequate control, clinicians should consider more invasive options such as botulinum toxin injections, phenol/alcohol nerve blocks, intrathecal baclofen therapy, or neurosurgical procedures (selective dorsal rhizotomy or dorsal root entry zone lesion). 8

It is essential to distinguish true spasticity (velocity‑dependent hyperactivity of stretch reflexes) from general muscle weakness or hypotonia; tizanidine improves spasticity but may exacerbate hypotonia and should not be used in that context. 8